Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of neoadjuvant mFOLFOX6 followed by surgery for locally advanced rectal cancer (R-NAC01)
jRCTs011180028Completed
- Start
- Mar 2014
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of oxaliplatin, folinic acid and fluorouracil in rectal cancer. Primary endpoint: percentage of postoperative complications. Started Mar 2014; status: completed.
02
Drugs
oxaliplatinfolinic acidfluorouracil
03
Conditions
rectal cancer
Beyond the preview
Go deeper on jRCTs011180028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs011180028.